Related Experiment Video
Updated: Jul 25, 2026

Defining Substrate Specificities for Lipase and Phospholipase Candidates
Published on: November 23, 2016
Phospholipase A2 is present in meconium and inhibits the activity of pulmonary surfactant: an in vitro study
A J Schrama1, A J de Beaufort, Y R Sukul
1Department of Pediatrics, Leiden University Medical Center, The Netherlands. A.J.J.Schrama@kgc.azl.nl
Unlabelled:
Atelectasis, a major contributor to pulmonary dysfunction in meconium aspiration syndrome (MAS), is produced by bronchiolar obstruction and surfactant inactivation. It has been shown that substances in meconium, e.g. fatty acids, inhibit surfactant activity. However, the role of the enzyme phospholipase A2 (PLA2), which hydrolyses surfactant in adult respiratory distress syndrome (ARDS), has not yet been studied. Our objective was to investigate whether PLA2 is present in meconium and inhibits pulmonary surfactant activity in vitro. Therefore, the presence of PLA2 activity in meconium, collected from 10 newborns, was measured by the formation of lysophosphatidylcholine after incubation of meconium with radioactively labelled dipalmitoylphosphatidylcholine. Meconium was fractionated by Sephadex G-100 column chromatography and the fractions were assayed for PLA2 activity. Also, their effect on the surface tension of surfactant (Curosurf) was measured using a pulsating bubble surfactometer (PBS). PLA2 activity was present in all meconium samples. Addition of meconium to surfactant significantly increased surface tension (mean +/- SD: 1.7 +/- 1.6 mN/m to 24.3 +/- 6.7 mN/m, p = 0.0001) and only the addition of the PLA2 containing fraction from meconium to surfactant also significantly increased surface tension (mean 1.7 +/- 1.6 mN/m to 19.0 +/- 3.58 mN/m, p < 0.0001).
Conclusion:
PLA2 is present in meconium and inhibits the activity of pulmonary surfactant in vitro. Therefore, PLA2 in meconium may contribute to surfactant inactivation and alveolar atelectasis in MAS.
Insights
Phospholipase A2 (PLA2) is found in meconium and inactivates pulmonary surfactant, potentially causing atelectasis in newborns with meconium aspiration syndrome (MAS). This study confirms PLA2
Area of Science:
- Neonatal respiratory medicine
- Biochemistry
- Pulmonary physiology
Background:
- Atelectasis is a primary cause of respiratory issues in meconium aspiration syndrome (MAS).
- Meconium components, such as fatty acids, are known to inhibit pulmonary surfactant function.
- The role of phospholipase A2 (PLA2), an enzyme implicated in surfactant hydrolysis in adult respiratory distress syndrome (ARDS), remained uninvestigated in MAS.
Purpose of the Study:
- To determine the presence and activity of PLA2 in meconium.
- To evaluate the inhibitory effect of meconium-derived PLA2 on pulmonary surfactant activity in vitro.
Main Methods:
- Meconium samples from 10 newborns were analyzed for PLA2 activity by measuring lysophosphatidylcholine formation from labeled dipalmitoylphosphatidylcholine.
- Meconium was fractionated using Sephadex G-100 column chromatography.
- The effect of meconium and its fractions on Curosurf (pulmonary surfactant) activity was assessed using a pulsating bubble surfactometer (PBS) by measuring surface tension.
Main Results:
- PLA2 activity was detected in all tested meconium samples.
- The addition of meconium significantly increased the surface tension of pulmonary surfactant (from 1.7 +/- 1.6 mN/m to 24.3 +/- 6.7 mN/m, p = 0.0001).
- A PLA2-containing fraction isolated from meconium also significantly increased surfactant surface tension (from 1.7 +/- 1.6 mN/m to 19.0 +/- 3.58 mN/m, p < 0.0001).
Conclusions:
- Phospholipase A2 (PLA2) is present in meconium.
- Meconium-derived PLA2 inhibits pulmonary surfactant activity in vitro.
- PLA2 in meconium may be a contributing factor to surfactant inactivation and subsequent alveolar atelectasis in MAS.
More Related Videos
08:49Fluorescence-Based Measurements of Phosphatidylserine/Phosphatidylinositol 4-Phosphate Exchange Between Membranes
Published on: March 14, 2021
10:31A Liposome Membrane Permeability Assay for Investigating the Effects of Phosphatidylinositol Phosphate Groups on Membranotropic Action of Venom PLA2
Published on: September 26, 2025
Related Concept Videos
Lipid Digestion
Breathing
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Surface Active Agents